Autophagy in Health and Disease

Erscheinungsjahr 2012
ISBN: 978-0-12-385101-7
Verlag: Elsevier Science

Buch, Englisch, 240 Seiten, Format (B × H): 197 mm x 241 mm, Gewicht: 664 g

Autophagy in Health and Disease offers an overview of the latest research in autophagy with a translational emphasis. This publication takes scientific research in autophagy a step further and offers integrated content with advancements in autophagy from cell biology and biochemical research to clinical treatments. A necessary reference for the bookshelf of medical and scientific researchers and students, Autophagy in Health and Disease presents high quality, reputable information on autophagy, allowing the reader quick access to the most applicable information.

Zielgruppe

Researchers, graduate students, and professionals studying autophagy across cell biology, biochemistry, medicine, and biomedical sciences.

Autoren/Hrsg.

Gottlieb, Roberta A

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Biomedizin, Medizinische Forschung, Klinische Studien
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Vorklinische Medizin: Grundlagenfächer Molekulare Medizin, Zellbiologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Vorklinische Medizin: Grundlagenfächer Biochemie (med.)
• Naturwissenschaften Biowissenschaften Biochemie (nichtmedizinisch)
• Naturwissenschaften Biowissenschaften Zellbiologie

Inhaltsverzeichnis

- Overview: Removal of Aggregates and Organelles
- Machinery and Genetics of Autophagy
- Autophagy in the Cardiovascular System
- Autophagy in the Immune System
- Autophagy in the GI Tract
- Autophagy in the Endocrine System
- Development
- Diabetes and Metabolic Syndrome
- Ischemia/Reperfusion
- Drug Discovery
- Measuring Autophagy in Vivo
- Aging, Nutrition, and Lifestyle

Über Autor(innen)

Gottlieb, Roberta A
Dr. Gottlieb has been conducting NIH-funded cardiovascular research for the past 20 years. She has prior experience with The Scripps Research Institute (TSRI); SDSU where she became the first Director of the Donald P. Shiley BioScience Center, and currently as the Director of Molecular Cardiobiology at Cedars-Sinai Heart Institute.
The work in her lab has led to the discovery of the cardioprotective agents and the elucidation of their novel mechanism of action. Her expertise in cardioprotection and autophagy is recognized on a national and international level.
Dr. Gottlieb is also an entrepreneur, having started a biotechnology company called Radical Therapeutix, to develop drugs to mitigate the damage to the heart during myocardial infarction. Dr. Gottlieb received her B.S. and M.D. degrees from Johns Hopkins University.